Cargando…

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda

BACKGROUND: Accurate diagnosis of tuberculosis, especially by using rapid molecular assays, can reduce transmission of drug resistant tuberculosis in communities. However, the frequency of resistance conferring mutations varies with geographic location of Mycobacterium tuberculosis, and this affects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kigozi, Edgar, Kasule, George W., Musisi, Kenneth, Lukoye, Deus, Kyobe, Samuel, Katabazi, Fred Ashaba, Wampande, Eddie M., Joloba, Moses L., Kateete, David Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976185/ https://www.ncbi.nlm.nih.gov/pubmed/29847567 http://dx.doi.org/10.1371/journal.pone.0198091

Ejemplares similares

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
por: Kasule, George W., et al.
Publicado: (2016)

Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)
por: Kateete, David Patrick, et al.
Publicado: (2019)

Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays
por: Wayengera, Misaki, et al.
Publicado: (2017)

Rhomboids of Mycobacteria: Characterization Using an aarA Mutant of Providencia stuartii and Gene Deletion in Mycobacterium smegmatis
por: Kateete, David Patrick, et al.
Publicado: (2012)

Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia
por: Tachbele, Erdaw, et al.
Publicado: (2021)

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016)

Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda
por: Ocan, Moses, et al.
Publicado: (2022)

Disproportionate Distribution of HBV Genotypes A and D and the Recombinant Genotype D/E in the High and Low HBV Endemic Regions of Uganda: A Wake-Up Call for Regional Specific HBV Management
por: Kafeero, Hussein Mukasa, et al.
Publicado: (2022)

Pertussis Prevalence and Its Determinants among Children with Persistent Cough in Urban Uganda
por: Kayina, Vincent, et al.
Publicado: (2015)

Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
por: Kia, Praiscillia, et al.
Publicado: (2023)

Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda
por: Mayanja, Richard, et al.
Publicado: (2023)

High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda
por: Kateete, David P, et al.
Publicado: (2011)

Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda
por: Wampande, Eddie M., et al.
Publicado: (2019)

Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda
por: Ocan, Moses, et al.
Publicado: (2016)

Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings
por: Mboowa, Gerald, et al.
Publicado: (2021)

Determination of circulating Mycobacterium tuberculosis strains and transmission patterns among pulmonary TB patients in Kawempe municipality, Uganda, using MIRU-VNTR
por: Nabyonga, Lydia, et al.
Publicado: (2011)

Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey
por: Lukoye, Deus, et al.
Publicado: (2013)

Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy
por: Kateete, David Patrick, et al.
Publicado: (2021)

Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda
por: Dickman, Katherine R, et al.
Publicado: (2010)

DNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda
por: Asiimwe, Benon B, et al.
Publicado: (2009)

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
por: Lukoye, Deus, et al.
Publicado: (2015)

CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda
por: Kateete, David Patrick, et al.
Publicado: (2019)

Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory
por: Kabugo, Joel, et al.
Publicado: (2021)

Predominance of Uganda genotype of Mycobacterium tuberculosis isolated from Ugandan patients with tuberculous lymphadenitis
por: Wamala, Dan, et al.
Publicado: (2015)

Isoniazid and Rifampicin Resistance-Conferring Mutations in Mycobacterium tuberculosis Isolates from South Africa
por: Traoré, Afsatou Ndama, et al.
Publicado: (2023)

Distribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda
por: Wampande, Eddie M., et al.
Publicado: (2015)

Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease
por: Wampande, Eddie M, et al.
Publicado: (2013)

Prevalence and Antimicrobial Susceptibility Patterns of Bacteria from Milkmen and Cows with Clinical Mastitis in and around Kampala, Uganda
por: Kateete, David Patrick, et al.
Publicado: (2013)

Clinico-pathological features of tuberculosis due to Mycobacterium tuberculosis Uganda genotype in patients with tuberculous lymphadenitis: a cross sectional study
por: Wamala, Dan, et al.
Publicado: (2014)

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
por: Ogwang, Sam, et al.
Publicado: (2009)

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
por: Sekaggya Wiltshire, Christine, et al.
Publicado: (2014)

Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda
por: Nakku-Joloba, Edith, et al.
Publicado: (2022)

Fatal poisoning by isoniazid and rifampicin
por: Sridhar, A., et al.
Publicado: (2012)

Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
por: Micheni, Lisa Nkatha, et al.
Publicado: (2021)

Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Uganda
por: Nakiyingi, Lydia, et al.
Publicado: (2012)

Sero-diagnosis of Active Mycobacterium tuberculosis Disease among HIV Co-infected Persons using Thymidylate Kinase based Antigen and Antibody Capture Enzyme Immuno-Assays
por: Wayengera, Misaki, et al.
Publicado: (2017)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8an26j0fl840qmn6v9a6nf049j